| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9470 |
| Human Intestinal Absorption | HIA+ | 0.5064 |
| Caco-2 Permeability | Caco2- | 0.5674 |
| P-glycoprotein Substrate | Non-substrate | 0.8470 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9886 |
| Non-inhibitor | 0.9848 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9592 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7937 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8075 |
| CYP450 2D6 Substrate | Non-substrate | 0.9331 |
| CYP450 3A4 Substrate | Non-substrate | 0.7966 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.9423 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9524 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9429 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9707 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9532 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9932 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9765 |
| Non-inhibitor | 0.9921 |
| AMES Toxicity | Non AMES toxic | 0.8645 |
| Carcinogens | Non-carcinogens | 0.5178 |
| Fish Toxicity | High FHMT | 0.8523 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9668 |
| Honey Bee Toxicity | High HBT | 0.7544 |
| Biodegradation | Ready biodegradable | 0.9656 |
| Acute Oral Toxicity | III | 0.5939 |
| Carcinogenicity (Three-class) | Non-required | 0.7142 |